Pfizer – Medical Alley Association

In The Know: Healthcare News for April 26, 2021

Vyant Bio, Inc., Ordaōs Bio, and Cellaria, Inc. Announce Collaboration to Design and Qualify Biomarker-Specific Small Protein Therapeutics Endeavour Vision Closes Endeavour Medtech Growth II LP at USD 375m to Invest in Transformative Healthcare Technologies Celcuity Licensing Deal with Pfizer Drives Stock Up 85% in One Week One Year Out From Series B, Senior Care […]

In The Know: Healthcare News for April 12, 2021

Bright Health Acquires Zipnosis, Enters Telehealth Market ANI Pharmaceuticals Expands Branded Products Portfolio Through Acquisition of Sandoz Inc. NDAs Celcuity Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Gedatolisib, a First-in-Class PI3K/mTOR Inhibitor for Breast Cancer Cardiovascular Systems, Inc. Announces Investment and Acquisition Option Agreement With Telehealth Company, CarePICS, LLC Nicole Walker Named […]

Pfizer Establishes New Program to Support Continued Biotechnology Innovation

Pfizer Breakthrough Growth Initiative will invest up to $500 million across a portfolio of clinical-stage biotechnology companies June 02, 2020 06:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to $500 million in biotechnology companies to help […]

In the Know: Healthcare News for May 20, 2019

Abbott Partners With NIH On BRAIN Initiative to Advance Research for Neurological Disorders Generic drugmaker Upsher-Smith plans Maple Grove expansion CVRx data show its device can benefit heart-failure patients 76% of Patients Positively Impacted Within 12 weeks in new MIRODERM Clinical Study Bright Health to expand into 5 new states next year VentureMed Group Grows […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER